Innovations

The collection and preservation of biological material for further DNA and RNA analysis are critical to many biomedical fields, from medical diagnostics to forensics and biodiversity conservation. The Forensic DNA lab at the University of the Western Cape has developed a novel, proprietary DNA

HIV/AIDS continues to disproportionately impact sub-Saharan Africa, where it remains a leading cause of illness and death among children. Paediatric HIV progresses at an alarming rate, with 20–30% of untreated infants succumbing to the disease within their first year. Without timely intervention

The recombinant LSDV-BCoV vaccine is an innovative dual vaccine designed to provide simultaneous protection against Lumpy Skin Disease Virus (LSDV) and Bovine Coronavirus (BCoV). It utilises a recombinant LSDV vector to express key BCoV antigens, including the spike (S1 and S2 subunits) and

Drug regimens have not been optimised for individuals of African descent. This is due to several converging factors, including Africa’s diverse genetics, disproportionate disease burdens (and consequently a high dependency on specific drug regimens), as well as under-representation of local

Monoclonal antibodies (mAbs) are immune system proteins that are used in targeted drug therapy and prophylaxis and are in high demand around the world to fight diseases. Despite advancements in biomedical technology, current methods for producing mAbs – primarily mammalian cell cultures – can be